Examples
| Generic Name | Brand Name |
|---|
| abciximab | ReoPro |
| eptifibatide | Integrilin |
| tirofiban | Aggrastat |
How It Works
These medicines prevent the formation of blood clots.
Why It Is Used
Glycoprotein IIb/IIIa inhibitors are typically used along with
angioplasty, stenting, or atherectomy procedures. Glycoprotein IIb/IIIa
inhibitors help prevent reclosure of the blood vessel (restenosis) after these
procedures.1 These medicines are often used along with
ASA and heparin.
How Well It Works
After angioplasty
Glycoprotein IIb/IIIa inhibitors may reduce the chance of a heart
attack when used after angioplasty with stenting and in people with unstable
angina.2 Although these medicines appear to be
useful when given immediately after angioplasty and stenting, long-term use has
not proven beneficial.
Abciximab is generally preferred over eptifibatide when
angioplasty is performed. Abciximab has been shown to reduce the rate of future
heart attack after angioplasty.3
Glycoprotein IIb/IIIa inhibitors may lower the risk of death in
people who have angioplasty after a heart attack.4
Side Effects
Some side effects of these medicines may include:
- Increased bleeding (hemorrhage) in the brain,
stomach, intestines, or other internal organs.
- Increased
bruising.
- Stomach irritation.
- Allergic reaction.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
If you have unstable angina and are at medium to high risk of a
heart attack, you may be a candidate for glycoprotein IIb/IIIa
inhibitors.5
Glycoprotein IIb/IIIa inhibitors are only used in the hospital,
such as before or after an angioplasty.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.